Chemicals in medicine

• Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions (23 Sep 2024)
  
• Regulation and marketing of cannabidiol-containing products in European countries. Pharmacists’ knowledge in Bulgaria (16 Sep 2024)
  
• Pharmacology and drug interactions of cannabinoids (16 Sep 2024)
  
• Epidiolex (Cannabidiol) Primer: Frequently Asked Questions for Patients and Caregivers (16 Sep 2024)
  
• Drug–Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain (02 Sep 2024)
  
• Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM (02 Sep 2024)
  
• Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis (24 May 2024)
  
• Exploring cannabinoid bioavailability in the medical cannabis industry (25 Jul 2022)
  
• Single Compound vs. Whole Plant CBD (20 Jul 2022)
  
• How to use CBD & Cannabis (20 Jul 2022)
  
• Very high doses of CBD, a cannabis component, don’t affect driving (18 Jul 2022)
  
• Tablet containing CBD shows promise in reducing post-operative pain (18 Jul 2022)
  
• Study provides insights on the effects of cannabidiol on severe form of epilepsy (18 Jul 2022)